Literature DB >> 1428942

Rapid molecular diagnosis of hemoglobin variants by RT-PCR of reticulocyte mRNA and direct sequencing.

T C Liu1, J S Yen, J S Shen, Y H Chen, L S Lee, P H Chen, J G Chang.   

Abstract

We have developed a rapid and simple approach for the molecular characterization of hemoglobin variants by a one-step reverse transcription-polymerase chain reaction of reticulocyte mRNA and direct sequencing of the product. This method can selectively amplify the alpha 1- or alpha 2-globin gene or the beta-globin gene transcript. The amino acid substitution of Hb G-Taichung is due to a G----C mutation at codon 74 of the alpha 1-globin gene, that of Hb J-Meinung to a G----A substitution at codon 56 of the beta-globin gene, and that of Hb Kaohsiung (or New York) to a T----A substitution at codon 113 of the beta-globin gene. The amplified segment encompassed the sequence from upstream of the initial codon behind the Cap site to downstream of the terminal codon before the polyadenylation addition signal. Hence, all hemoglobin variants should be able to be characterized by this approach.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428942     DOI: 10.3109/03630269209005689

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  PCR-based analysis of alpha-thalassemia in Southern Taiwan.

Authors:  Tyen-Po Chen; Ta-Chih Liu; Chao-Sung Chang; Jang-Gowth Chang; Hui-Jen Tsai; Sheng-Fung Lin
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Rapid detection of hemoglobin variants by mutagenically separated polymerase chain reaction (MS-PCR).

Authors:  J G Chang; C P Chang; C M Lu; J M Huang; J T Chen; H J Liu
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

3.  Rapid molecular characterization of Hb H disease in Chinese by polymerase chain reaction.

Authors:  J G Chang; T C Liu; L I Perng; S S Chiou; T P Chen; P H Chen; C P Lin
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.